Your browser doesn't support javascript.
loading
The future of International Classification of Diseases coding in steatotic liver disease: An expert panel Delphi consensus statement.
Hagström, Hannes; Adams, Leon A; Allen, Alina M; Byrne, Christopher D; Chang, Yoosoo; Duseja, Ajay; Grønbæk, Henning; Ismail, Mona H; Jepsen, Peter; Kanwal, Fasiha; Kramer, Jennifer; Loomba, Rohit; Mark, Henry E; Newsome, Philip N; Rinella, Mary E; Rowe, Ian A; Ryu, Seungho; Sanyal, Arun; Schattenberg, Jörn M; Serper, Marina; Sheron, Nick; Simon, Tracey G; Spearman, C Wendy; Tapper, Elliot B; Villota-Rivas, Marcela; Wild, Sarah H; Wong, Vincent Wai-Sun; Yilmaz, Yusuf; Zelber-Sagi, Shira; Åberg, Fredrik; Lazarus, Jeffrey V.
  • Hagström H; Department of Upper GI, Division of Hepatology, Karolinska University Hospital, Stockholm, Sweden.
  • Adams LA; Department of Medicine, Huddinge, Karolinska Institutet, Stockholm, Sweden.
  • Allen AM; Medical School, the University of Western Australia, Perth, Australia.
  • Byrne CD; Department of Medicine, Division of Gastroenterology and Hepatology, Mayo Clinic, Rochester, Minnesota, USA.
  • Chang Y; Nutrition and Metabolism, Faculty of Medicine, University of Southampton, Southampton, UK.
  • Duseja A; Southampton National Institute for Health Research Biomedical Research Centre, University Hospital Southampton, Southampton General Hospital, Southampton, UK.
  • Grønbæk H; Center for Cohort Studies, Total Healthcare Center, Kangbuk Samsung Hospital, Sungkyunkwan University School of Medicine, Seoul, Republic of Korea.
  • Ismail MH; Department of Hepatology, Postgraduate Institute of Medical Education and Research, Chandigarh, India.
  • Jepsen P; Department of Hepatology and Gastroenterology, Aarhus University Hospital, Aarhus, Denmark.
  • Kanwal F; Department of Internal Medicine, Division of Gastroenterology, King Fahd Hospital of the University, Al-Khobar, Saudi Arabia.
  • Kramer J; College of Medicine, Imam Abdulrahman Bin Faisal University, Dammam, Saudi Arabia.
  • Loomba R; Department of Hepatology and Gastroenterology, Aarhus University Hospital, Aarhus, Denmark.
  • Mark HE; Baylor College of Medicine and Michael E. DeBakey VA Medical Center, Houston, Texas, USA.
  • Newsome PN; Baylor College of Medicine and Michael E. DeBakey VA Medical Center, Houston, Texas, USA.
  • Rinella ME; NAFLD Research Center, Division of Gastroenterology and Epidemiology, University of California San Diego, La Jolla, California, USA.
  • Rowe IA; Independent consultant, Nottingham, UK.
  • Ryu S; National Institute for Health Research Birmingham Biomedical Research Centre at University Hospitals Birmingham NHS Foundation Trust and the University of Birmingham, Birmingham, UK.
  • Sanyal A; Centre for Liver and Gastrointestinal Research, Institute of Immunology and Immunotherapy, University of Birmingham, Birmingham, UK.
  • Schattenberg JM; Department of Medicine, University of Chicago, Chicago, Illinois, USA.
  • Serper M; Leeds Institute for Medical Research, University of Leeds, Leeds, UK.
  • Sheron N; Center for Cohort Studies, Total Healthcare Center, Kangbuk Samsung Hospital, Sungkyunkwan University School of Medicine, Seoul, Republic of Korea.
  • Simon TG; Department of Clinical Research Design and Evaluation, SAIHST, Sungkyunkwan University, Seoul, Republic of Korea.
  • Spearman CW; Department of Internal Medicine, Stravitz-Sanyal Institute of Liver Disease and Metabolic Health, VCU School of Medicine and Health System and Division of Gastroenterology, VCU School of Medicine, Richmond, Virginia, USA.
  • Tapper EB; Department of Internal Medicine II, University Hospital of Saarland, Homburg, Germany.
  • Villota-Rivas M; Department of Medicine, Division of Gastroenterology and Hepatology, University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania, USA.
  • Wild SH; The Roger Williams Institute of Hepatology, Foundation for Liver Research, Kings College London.
  • Wong VW; Division of Gastroenterology and Hepatology, Massachusetts General Hospital, Boston, Massachusetts, USA.
  • Yilmaz Y; Harvard Medical School, Boston, Massachusetts, USA.
  • Zelber-Sagi S; Department of Medicine, Division of Hepatology, Faculty of Health Sciences, University of Cape Town, Cape Town, South Africa.
  • Åberg F; Division of Gastroenterology and Hepatology, University of Michigan, Ann Arbor, Michigan, USA.
  • Lazarus JV; Barcelona Institute for Global Health (ISGlobal), Hospital Clínic, University of Barcelona, Barcelona, Spain.
Hepatol Commun ; 8(2)2024 Feb 01.
Article en En | MEDLINE | ID: mdl-38315102
ABSTRACT

BACKGROUND:

Following the adoption of new nomenclature for steatotic liver disease, we aimed to build consensus on the use of International Classification of Diseases codes and recommendations for future research and advocacy.

METHODS:

Through a two-stage Delphi process, a core group (n = 20) reviewed draft statements and recommendations (n = 6), indicating levels of agreement. Following revisions, this process was repeated with a large expert panel (n = 243) from 73 countries.

RESULTS:

Consensus ranged from 88.8% to 96.9% (mean = 92.3%).

CONCLUSIONS:

This global consensus statement provides guidance on harmonizing the International Classification of Diseases coding for steatotic liver disease and future directions to advance the field.
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Clasificación Internacional de Enfermedades / Hepatopatías Tipo de estudio: Guideline Límite: Humans Idioma: En Año: 2024 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Clasificación Internacional de Enfermedades / Hepatopatías Tipo de estudio: Guideline Límite: Humans Idioma: En Año: 2024 Tipo del documento: Article